Is cytokine removal by continuous hemofiltration feasible?
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference52 articles.
1. Immunomodulation for Sepsis and Septic Shock;Calandra,1998
2. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group;Fisher;JAMA,1994
3. Treatment of septic shock with human monoclonal antibody HA-1A.A randomized, double-blind, placebo-controlled trial: CHESS Trial Study Group;McCloskey;Ann Intern Med,1994
4. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: A randomized, controlled, double-blind, multicenter clinical trial. RNF-Alpha Mab Sepsis Study Group;Abraham;JAMA,1995
5. Intersept: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group;Cohen;Crit Care Med,1996
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Massive release of TH2 cytokines induced a cytokine storm during a severe mast cell activation event in a patient with indolent systemic mastocytosis;Journal of Allergy and Clinical Immunology;2022-08
2. AN69 Filter Membranes with High Ultrafiltration Rates during Continuous Venovenous Hemofiltration Reduce Mortality in Patients with Sepsis-Induced Multiorgan Dysfunction Syndrome;Membranes;2021-10-29
3. Hemofiltration in the Management of Severe Pediatric Burns: Experience in a UK Burns Centre and Systematic Review;Journal of Burn Care & Research;2021-10-12
4. Effect of Extracorporeal Blood Purification on Mortality in Sepsis: A Meta-Analysis and Trial Sequential Analysis;Blood Purification;2020-10-28
5. Changing the terminology from kidney replacement therapy to kidney support therapy;Therapeutic Apheresis and Dialysis;2020-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3